Abstract
Lipid markers are well established predictors of vascular disease. The most frequently measured lipid variables are total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol and triglycerides. In this review we consider the predictive value of these variables and other more specialised related tests. We also discuss the effect of lipid altering drugs on these markers. The interaction of other vascular risk factors and the lipid effects of non-lipid altering drugs (e.g. blood pressure lowering agents) are also briefly described. Similarly, we discuss the effects of lipid lowering drugs on non-lipid vascular risk factors. Finally, we briefly consider the effect of altering the lipid profile on surrogate markers and events associated with atherosclerosis.
Keywords: coronary heart disease, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, lipids, total cholesterol, apolipoproteins, lipid lowering drugs
Current Pharmaceutical Design
Title: The Predictive Value of Lipid Markers in Vascular Disease
Volume: 11 Issue: 17
Author(s): H. J. Milionis, S. S. Daskalopoulou, M. Elisaf and D. P. Mikhailidis
Affiliation:
Keywords: coronary heart disease, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, lipids, total cholesterol, apolipoproteins, lipid lowering drugs
Abstract: Lipid markers are well established predictors of vascular disease. The most frequently measured lipid variables are total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol and triglycerides. In this review we consider the predictive value of these variables and other more specialised related tests. We also discuss the effect of lipid altering drugs on these markers. The interaction of other vascular risk factors and the lipid effects of non-lipid altering drugs (e.g. blood pressure lowering agents) are also briefly described. Similarly, we discuss the effects of lipid lowering drugs on non-lipid vascular risk factors. Finally, we briefly consider the effect of altering the lipid profile on surrogate markers and events associated with atherosclerosis.
Export Options
About this article
Cite this article as:
Milionis J. H., Daskalopoulou S. S., Elisaf M. and Mikhailidis P. D., The Predictive Value of Lipid Markers in Vascular Disease, Current Pharmaceutical Design 2005; 11 (17) . https://dx.doi.org/10.2174/1381612054367409
DOI https://dx.doi.org/10.2174/1381612054367409 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Epidemiology and Health Effects of Tobacco Use
Current Pediatric Reviews Nanocarriers for Tracking and Treating Diseases
Current Medicinal Chemistry Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design 5-HT7 Receptors
Current Drug Targets - CNS & Neurological Disorders Roles of CLR/RAMP Receptor Signaling in Reproduction and Development
Current Protein & Peptide Science Extra Virgin Olive Oil and Cardiovascular Diseases: Benefits for Human Health
Endocrine, Metabolic & Immune Disorders - Drug Targets NADPH Oxidase and Neurodegeneration
Current Neuropharmacology The Role of the Novel Adipocyte-Derived Protein Adiponectin in Human Disease: An Update
Mini-Reviews in Medicinal Chemistry Endothelial Dysfunction and Angiogenesis in Autosomal Dominant Polycystic Kidney Disease
Current Hypertension Reviews Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes
Current Drug Targets Intrauterine Intervention for the Treatment of Fetal Growth Restriction
Current Pediatric Reviews Fish Oil Fatty Acids as Cardiovascular Drugs
Current Vascular Pharmacology Is Hypertension an Inflammatory Process?
Current Pharmaceutical Design Blood Coagulation and the Risk of Atherothrombosis
Current Genomics Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Targeting STAT1 in Both Cancer and Insulin Resistance Diseases
Current Protein & Peptide Science Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection
Cardiovascular & Hematological Disorders-Drug Targets Patent Selections:
Recent Patents on Medical Imaging Functional, Genetic and Biochemical Biomarkers of Peripheral Arterial Disease
Current Medicinal Chemistry Subject Index to Volume 1
Vascular Disease Prevention (Discontinued)